Claris Lifesciences under income tax scrutiny
20 premises of Claris Lifesciences came under the radar of the Income Tax sleuths, including the commercial and, residential complexes of its promoters, and four sister companies in Gujarat
Residential apartments, offices and factory premises of the Gujarat-based Pharma Company, Claris Lifesciences recently came under the wide scrutiny of the Income Tax Department. A massive search operation including the commercial complexes as well as the residences of its promoters, and also the four sister concerns, is reported to have been a part of the search.
According to some sources reported to PTI, there was evidence related to tax evasion and suspected black money transaction found against the Claris promoters, according to an internal probe done by the IT department. No comments have been received from the company officials yet.
However, Stock exchange BSE said it has sought clarification from the company with respect to reports about I-T Department's search and survey at its premises.
As reported by PTI
Documents related to the pharma company, its affiliates as well papers linked to several bank lockers were found during the day-long operation, which will continue tomorrow, the sources said, adding Rs 1 crore cash was seized from the office of a senior Claris executive here.
The state-wide operation started at around 6.30 am with the help of as many as 150 personnel.
Apart from corporate office of Claris near Parimal Garden here, the I-T sleuths searched offices and other premises of four other companies owned by the promoters, including Abellon Clean Energy Ltd, Levana Financial Services and Flourish Pure Foods Pvt Ltd, they said.
A team also conducted search at the residences of the company's promoters and other key officials, including Managing Director Arjun Handa.
Another I-T team carried out survey at two factories -- Changodar near Ahmedabad and Modasa in north Gujarat.
Claris Lifesciences is a multi-business enterprise and the holding company of Claris Injectables, a wholly-owned subsidiary dealing in speciality injectables business.
The company manufactures and markets products across multiple delivery systems, markets, and therapeutic segments, including anaesthesia, blood products and anti-infectives.
Residential apartments, offices and factory premises of the Gujarat-based Pharma Company, Claris Lifesciences recently came under the wide scrutiny of the Income Tax Department. A massive search operation including the commercial complexes as well as the residences of its promoters, and also the four sister concerns, is reported to have been a part of the search.
According to some sources reported to PTI, there was evidence related to tax evasion and suspected black money transaction found against the Claris promoters, according to an internal probe done by the IT department. No comments have been received from the company officials yet.
However, Stock exchange BSE said it has sought clarification from the company with respect to reports about I-T Department's search and survey at its premises.
As reported by PTI
Documents related to the pharma company, its affiliates as well papers linked to several bank lockers were found during the day-long operation, which will continue tomorrow, the sources said, adding Rs 1 crore cash was seized from the office of a senior Claris executive here.
The state-wide operation started at around 6.30 am with the help of as many as 150 personnel.
Apart from corporate office of Claris near Parimal Garden here, the I-T sleuths searched offices and other premises of four other companies owned by the promoters, including Abellon Clean Energy Ltd, Levana Financial Services and Flourish Pure Foods Pvt Ltd, they said.
A team also conducted search at the residences of the company's promoters and other key officials, including Managing Director Arjun Handa.
Another I-T team carried out survey at two factories -- Changodar near Ahmedabad and Modasa in north Gujarat.
Claris Lifesciences is a multi-business enterprise and the holding company of Claris Injectables, a wholly-owned subsidiary dealing in speciality injectables business.
The company manufactures and markets products across multiple delivery systems, markets, and therapeutic segments, including anaesthesia, blood products and anti-infectives.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.